John Motyka: Real: Sounds like a real challenge...lol...jdm
May 17, 10:54 AM
•!Report Abuse
John Motyka eabyrd: ROSG w/ Reverse Split 1:12. Price moves illussionary. Must move much farther to get me even. So sad...jdm
May 16, 1:54 PM
Reply
(9)
•!Report Abuse
View all 9 replies
John Motyka: Ram: Keep in touch on ROSG, or anything else. ROSG has been underwater for a very long time. Nice to hear from someone else about it...jdm
Sun, 1:33 PM
•!Report Abuse
Ram B: Strong buys on OSIR!... Rosg still shooting but is now very over priced IMO; i believe it is now going to cool off. Look @ OSIR for moves
Mon, 1:29 PM
•!Report Abuse
John Motyka Husky: How surgery? Does MAKO pique your interest? Surgical future embraces Robotics as healthcare costcutter w/ zero defect outcomes...jdm
May 14, 1:46 PM
Reply
(2)
•!Report Abuse
View all 2 replies
FortSumter: They specialize in knee replacement. Huge market going forward. But until the S&P settle down, I'd wait. I'd like to get in too.
May 14, 1:53 PM
•!Report Abuse
John Motyka: Fort: Urge you to establish contact w/ 1tallrn. Clinical RN working w/ MAKO post-procedural patients. Friendly sort as well!...jdm
May 15, 2:01 PM
•!Report Abuse
John Motyka All:RPXC slides as investors turn from small cap speculation. Patent niche just a casualty of sector contraction. Do homework on this...jdm
May 14, 1:42 PM
Reply
•!Report Abuse
View all 0 replies
John Motyka RPXC: Silence from management. Why did this stock get crushed like this?...jdm
John Motyka: XLS: RPXC confirms Random Walk Theory of Price Movements? I was hoping for something more as the cause. sigh...jdm
May 11, 4:40 PM
•!Report Abuse
John Motyka Chines: Love the sound of "all long" when you say it. I continue to Hold my positions in EMC, LKQX, MAKO, TOO, WZE, ARCI and MITK...jdm
May 9, 2:24 PM
Reply
(2)
•!Report Abuse
View all 2 replies
Funkengruven: MAKO took a serious hit as of late... buying op for longs eh?
May 9, 3:10 PM
•!Report Abuse
John Motyka: Funk: sa offers articles about MAKO that are very recent. Has a future remaking ordinary ortho docs into revenue generating superstars...jdm
May 9, 3:38 PM
•!Report Abuse
John Motyka Chines: Love the sound of "all long" when you say it. I continue to Hold my positions in EMC, LKQX, MAKO, TOO, WZE, ARCI and MITK...jdm
May 9, 2:23 PM
Reply
•!Report Abuse
View all 0 replies
John Motyka Tooth:ROSG has only their Rna Lab Test as a viable asset. Management is flawed. Too bad..so sad...jdm
May 9, 2:19 PM
Reply
•!Report Abuse
View all 0 replies
John Motyka OK Shapiro; once is enough already!!! Let me guess...you are short on TASR. ...jdm
May 5, 1:03 PM
Reply
•!Report Abuse
View all 0 replies
John Motyka Adam: Wow! How good to see you found favor w/ one of my sleeper suggestions. I will expand my position 30%. Keep up the Good Press...jdm
May 4, 3:41 PM
Reply
•!Report Abuse
View all 0 replies
John Motyka Tooth: Been w/ ROSG for years. Gold Standard Rna Lab test is their only asset worth a buyout. No choice but to wait for it...jdm
May 4, 3:25 PM
Reply
•!Report Abuse
View all 0 replies
John Motyka GERN: Beats but still bleeds out. Patents and Phase III trail will tell the tale's outcome. Soon I hope. Nice entry point. Hold & Hope...jdm
May 4, 11:01 AM
Reply
(2)
•!Report Abuse
View all 2 replies
Funkengruven: "Hold & Hope" is all I can do at this point... so Holding and Hoping! GERN way long, LOL!!
John Motyka MITK Watchers: OUCH! Looks like this could turn into one wild and crazy ride. Great product in a vunerable situation. Management error...jdm
May 4, 10:55 AM
Reply
•!Report Abuse
View all 0 replies
John Motyka IBM: Todays volume figure from sa must be bogus...200,000shr @ 1525???...jdm
Apr 30, 3:26 PM
Reply
(2)
•!Report Abuse
View all 2 replies
Garfield23: strong money plays up, ibm, cde and silver, as weighted, 25%, 25%, 50%,
May 1, 2:39 PM
•!Report Abuse
John Motyka: Garfield~I had bigtime loses w/ CDE in the past. Careful there...pollution and litigation issues in the background...jdm
John Motyka